| MicroRNA signature refine response prediction in CML R Alves, AC Gonçalves, J Jorge, G Marques, D Luís, AB Ribeiro, ... Scientific Reports 9 (1), 9666, 2019 | 33 | 2019 |
| NKT-like (CD3+ CD56+) cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors JS Almeida, P Couceiro, N López-Sejas, V Alves, L Růžičková, ... Frontiers in immunology 10, 458998, 2019 | 25 | 2019 |
| Tumor-infiltrating lymphocytes and cancer markers in osteosarcoma: influence on patient survival JM Casanova, JS Almeida, JD Reith, LM Sousa, R Fonseca, ... Cancers 13 (23), 6075, 2021 | 22 | 2021 |
| Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without … R Alves, SEB McArdle, J Vadakekolathu, AC Gonçalves, ... Journal of Translational Medicine 18, 1-15, 2020 | 20 | 2020 |
| Tumor and peripheral immune status in soft tissue sarcoma: implications for immunotherapy LM Sousa, JS Almeida, T Fortes-Andrade, M Santos-Rosa, ... Cancers 13 (15), 3885, 2021 | 18 | 2021 |
| Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia R Alves, AC Gonçalves, J Jorge, J Alves, A Alves da Silva, ... Medical Oncology 36, 1-10, 2019 | 17 | 2019 |
| Long-term response after 94 cycles of trabectedin in a patient with metastatic leiomyosarcoma of the lower extremity M Cordeiro, JM Casanova, J Rodrigues, J Freitas, R Fonseca, ... Case reports in oncology 13 (1), 113-119, 2020 | 11 | 2020 |
| The role of natural killer cells in soft tissue sarcoma: prospects for immunotherapy T Fortes-Andrade, JS Almeida, LM Sousa, M Santos-Rosa, ... Cancers 13 (15), 3865, 2021 | 6 | 2021 |
| Effect of age on NK cell compartment in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors P Rodrigues-Santos, N López-Sejas, JS Almeida, L Ruzičková, ... Frontiers in immunology 9, 2587, 2018 | 6 | 2018 |
| Genetic variants of ABC and SLC transporter genes and chronic myeloid leukaemia: impact on susceptibility and prognosis R Alves, AC Gonçalves, J Jorge, G Marques, AB Ribeiro, R Tenreiro, ... International Journal of Molecular Sciences 23 (17), 9815, 2022 | 4 | 2022 |
| PS1170 INFLUX/EFFLUX TRANSPORTERS IN CHRONIC MYELOID LEUKEMIA: THE INFLUENCE OF GENETIC VARIANTS ON SUSCEPTIBILITY AND DRUG RESPONSE RS Alves, A Gonçalves, J Jorge, G Marques, AB Ribeiro, R Tenreiro, ... HemaSphere 3 (S1), 532, 2019 | 2 | 2019 |
| The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy. Cancers 2021, 13, 3865 T Fortes-Andrade, JS Almeida, LM Sousa, M Santos-Rosa, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| PF401 IMMUNE SYSTEM AND CHRONIC MYELOID LEUKEMIA: THE IMPACT OF TYROSINE KINASE INHIBITORS RS Alves, SE McArdle, J Vadakekolathu, AC Gonçalves, ... HemaSphere 3, 152-153, 2019 | | 2019 |
| KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS ASSOCIATED WITH SUSCEPTIBILITY AND MOLECULAR RESPONSE TO TYROSINE KINASE INHIBITOR THERAPY IN CHRONIC MYELOID LEUKEMIA P Rodrigues-Santos, P Couceiro, S Oliveira, JS Almeida, V Alves, ... HLA 93 (5), 401-401, 2019 | | 2019 |
| Genetic variability of influx and efflux transporters: the impact on susceptibility to chronic myeloid leukemia development R Alves, AC Goncalves, J Jorge, G Marques, AB Ribeiro, R Tenreiro, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 49, 219-219, 2019 | | 2019 |
| Effect of age on NK cell compartment in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors PR Santos, N López Sejas, JS Almeida, L Ruzickova, P Couceiro, V Alves, ... Frontiers Media, 2018 | | 2018 |
| SOLUBLE AND MEMBRANE-BOUND RECEPTOR-LIGAND IMMUNE CHECKPOINTS AND CHRONIC MYELOID LEUKEMIA: CORRELATIONS WITH MOLECULAR RESPONSE AND TYROSINE KINASE INHIBITOR THERAPY P Rodrigues-Santos, JS Almeida, P Couceiro, V Alves, JR Simplicio, ... HAEMATOLOGICA 102, 430-431, 2017 | | 2017 |
| THE ROLE OF MICRORNAS IN CHRONIC MYELOID LEUKEMIA THERAPEUTIC SELECTION R Alves, AC Goncalves, P Couceiro, P Rodrigues-Santos, ... HAEMATOLOGICA 102, 438-438, 2017 | | 2017 |
| TRANSCRIBED ULTRACONSERVED NONCODING RNAS (T-UCRS) IN CHRONIC MYELOID LEUKEMIA: EXPRESSION PROFILES ASSOCIATED WITH MOLECULAR RESPONSE TO THERAPY WITH TYROSINE KINASE INHIBITORS P Rodrigues Santos, P Abranches, P Couceiro, JR Simplicio, JS Almeida, ... HAEMATOLOGICA 102, 429-430, 2017 | | 2017 |
| LEUKEMIC STEM CELLS DEFINED BY DIPEPTIDIL-PEPTIDASE IV (CD26) EXPRESSION IN CD34+ CD38-STEM CELLS AND TYROSINE KINASE INHIBITOR THERAPY IN CHRONIC MYELOID LEUKEMIA P Rodrigues Santos, J Almeida, P Couceiro, V Alves, L Ruzickova, ... HAEMATOLOGICA 101, 730-731, 2016 | | 2016 |
Paulo Rodrigues SantosInstitute of Immunology - Fac Medicine University of Coimbra - PortugalVerified email at uc.pt
